Add to ORKGPortuguese familial amyloidotic polyneuropathy (FAP) type I is a systemic amyloidotic disease due to an amyloidogenic transthyretin (TTR) protein, in which an amino acid substitution of methionine for valine at position 30 of TTR molecule is present1
Familial amyloidotic polyneuropathy (FAP) is an inherited disorder with the systemic deposition of a...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
The treatment of familial amyloid polyneuropathy (FAP) requires a multidisciplinary approach, mainly...
AUTOSOMAL dominant amyloidoses characterized sofar are most commonly associated with transthyretin (...
Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant disorder associated with more tha...
FAMILIAL amyloid polyneuropathy (FAP) is the mostcommon form of herederitary amyloidosis. Initial cl...
Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is caused by gain-of-toxic-function ...
FAMILIAL amyloidotic polyneuropathy (FAP) is aninherited autosomal dominant systemic disease cause
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
In the literature, concepts of “polyneuropathy”, “peripheral neuropathy” and “neuropathy” are often ...
Ernst HundDepartment of Neurology, University of Heidelberg, Heidelberg, GermanyAbstract: Transthyre...
Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease characterized by deposition o...
Familial amyloidotic polyneuropathy (FAP) is an inherited disease characterized by an abnormal syste...
Transplant Proc. 2003 May;35(3):1116-20. End-stage renal disease in familial amyloidosis ATTR Val...
Familial amyloid polyneuropathy (FAP) is characterized by deposition of mutated transthyretin (TTR) ...
Familial amyloidotic polyneuropathy (FAP) is an inherited disorder with the systemic deposition of a...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
The treatment of familial amyloid polyneuropathy (FAP) requires a multidisciplinary approach, mainly...
AUTOSOMAL dominant amyloidoses characterized sofar are most commonly associated with transthyretin (...
Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant disorder associated with more tha...
FAMILIAL amyloid polyneuropathy (FAP) is the mostcommon form of herederitary amyloidosis. Initial cl...
Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) is caused by gain-of-toxic-function ...
FAMILIAL amyloidotic polyneuropathy (FAP) is aninherited autosomal dominant systemic disease cause
Familial amyloidotic polyneuropathy type 1 (FAP1, MIM176300) is an autosomal dominant disease caused...
In the literature, concepts of “polyneuropathy”, “peripheral neuropathy” and “neuropathy” are often ...
Ernst HundDepartment of Neurology, University of Heidelberg, Heidelberg, GermanyAbstract: Transthyre...
Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease characterized by deposition o...
Familial amyloidotic polyneuropathy (FAP) is an inherited disease characterized by an abnormal syste...
Transplant Proc. 2003 May;35(3):1116-20. End-stage renal disease in familial amyloidosis ATTR Val...
Familial amyloid polyneuropathy (FAP) is characterized by deposition of mutated transthyretin (TTR) ...
Familial amyloidotic polyneuropathy (FAP) is an inherited disorder with the systemic deposition of a...
Hereditary amyloidoses form a clinically and genetically heterogeneous group of autosomal-dominantly...
The treatment of familial amyloid polyneuropathy (FAP) requires a multidisciplinary approach, mainly...